News

The Total Tutor Interviews CEO David Hall on BlogTalkRadio

10 years ago Feb 19, 2015

RepliCel’s CEO David Hall is interviewed by The Total Tutor Neil Haley on blogtalkradio. Hall...

Houston Style Magazine Interviews RepliCel CEO

10 years ago Feb 03, 2015

New Treatment for NFL Players and Pro Athletes Offers New HopeStory by: Jo-CarolynNew York, NY,...

CEO David Hall Interviewed on ESPN New York Radio

10 years ago Jan 27, 2015

To listen to the full interview, click here or view the file below. CEO &...

RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC

10 years ago Jan 19, 2015

VANCOUVER, BC – January 20, 2015 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF),...

RepliCel Life Sciences to Present at Biotech Showcase 2015

10 years ago Jan 06, 2015

Meetings focused on investors, analysts, and potential partners for RCS-01 and RCT-01 cell therapiesVANCOUVER, BC...

Newly Released Peer-Reviewed Publication Further Validates RepliCels Use of Dermal Sheath Cup Cells to Treat Pattern Baldness

10 years ago Dec 21, 2014

VANCOUVER, BC – December 22, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP),...

VP Lee Buckler Podcast Interview by Midas Letter

10 years ago Dec 18, 2014

Written By: James West Listen to the full interview here. RepliCel’s VP Lee Buckler explains...

Chronic Achilles Tendinosis Video Launched

10 years ago Dec 01, 2014

Using Your Own Cells to Heal Tendon InjuriesRepliCel is developing an autologous cell-based product for...

RepliCel Life Sciences to Present at World Stem Cell Summit 2014

10 years ago Dec 01, 2014

Over multiple sessions, Lee Buckler will present a RepliCel update, participate in session panels, and...

RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis

10 years ago Nov 30, 2014

Health Canada Issues “No Objection Letter” for RepliCel’s Phase 1/2 Clinical Trial of RCT-01 VANCOUVER,...

RepliCel Announces 2014 Third Quarter Financial Results

10 years ago Nov 25, 2014

VANCOUVER, BC – November 26, 2014 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

November 7, 2014 – R. Lee Buckler: How RepliCel is Harnessing the Awesome Power of Cell Therapy

10 years ago Nov 06, 2014

To read the full report, click here: R. Lee Bucker on RepliCel Life SciencesRegenerative medicine...

RepliCel Submits Clinical Trial Application to Health Canada for its Chronic Achilles Tendinosis Trial

10 years ago Oct 28, 2014

Autologous cell therapy, RCT-01, to be investigated for treatment of tendinopathies refractory to other treatments...

Midas Letter Interviews CEO David Hall

10 years ago Oct 23, 2014

To listen to the full interview podcast and read the transcript click here: Midas Letter...

Japan Gives a Hug to the Cell Therapy Industry: R. Lee Buckler

10 years ago Oct 21, 2014

To read the full report click here: R. Lee Buckler on the Cell Therapy IndustryLast...

Seeking Alpha – Why RepliCel is a Promising Under-Researched Small-Cap Biotech

10 years ago Oct 09, 2014

By: Eric Chiu, Biotech, Healthcare Contributor Published October 10, 2014To read the entire article as...

RepliCel to Present Commercial and Clinical Update at BioJapan 2014 World Business Forum

10 years ago Oct 08, 2014

Japanese meetings to focus on partnering VANCOUVER, BC – October 9, 2014 – RepliCel Life...

RepliCel Life Sciences Adds Industry Specialist to Management Team

10 years ago Oct 06, 2014

Newly Appointed Vice-President of Business & Corporate Development to Drive External Initiatives VANCOUVER, BC –...

RepliCel to Present Clinical Trial Update at Stem Cell Meeting on the Mesa Partnering Forum in California

10 years ago Oct 01, 2014

VANCOUVER, BC – October 2, 2014 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF),...

Seeking Alpha Article – RepliCel Offers Significant Upside

10 years ago Sep 24, 2014

To view the article as it appears on Seeking Alpha, click here.Summary RepliCel is a...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.